FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Imipenem and Cilastatin for Injection, USP
Status: Currently in Shortage
»Date first posted: 05/22/2015
»Therapeutic Categories: Anti-Infective

Expand all

Fresenius Kabi USA, LLC (Reverified 09/08/2016)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
250 mg/250 mg per vial, single dose vial, sterile powder (NDC 63323-349-25) Available Check wholesaler inventory Delay in shipping of the drug
500 mg/500 mg per vial, single dose vial, sterile powder (NDC 63323-322-25) Available Check wholesaler inventory Delay in shipping of the drug

Hospira, Inc. (Revised 09/19/2016)

Company Contact Information:
877-946-7747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg/500 mg Single Dose Glass Fliptop Vial (NDC 0409-3507-01) Available Available Other
250 mg/250 mg Single Dose Glass Fliptop Vial (NDC 0409-3508-01) Available Available Other

Merck Sharp & Dohme Corp. (Revised 06/24/2016)

Company Contact Information:
800-672-6372

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg imipenem equivalent and 500 mg cilastatin equivalent and 20 mg sodium bicarbonate as a buffer in trays of 25 vials (NDC 0006-3516-59) Product available. Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.